| Literature DB >> 26182155 |
Genryu Hirano1, Atsushi Fukunaga2, Tetsuro Sohda2, Hideo Kunimoto2, Kaoru Yotsumoto2, Kunitoshi Sakurai2, Hideyuki Iwashita2, Shuichi Ueda2,3, Keiji Yokoyama2, Daisuke Morihara2,3, Yoshitaka Tomioka2, Akira Anan2, Masashi Yamaguchi2, Yasuaki Takeyama2, Kouichi Eguchi2, Masaharu Sakamoto2,3, Makoto Irie2, Kaoru Iwata2, Satoshi Shakado2, Kunihiko Aoyagi2, Shotaro Sakisaka2,3.
Abstract
A 54-year-old male was treated for chronic hepatitis C with pegylated interferon (PEG-IFN) α-2a administered for 24 weeks. HCV-RNA was negative at 24 weeks after treatment, showing sustained virological response (SVR). Abdominal distention and diarrhea were observed 28 weeks after commencing the treatment, i.e., 4 weeks after completing treatment. The elevation of eosinophil count was observed in blood tests and ascites, and because eosinophilic infiltration was also observed on gastrointestinal histopathology, the patient was diagnosed with eosinophilic enteritis. As the eosinophil count spontaneously improved and abdominal symptoms disappeared, the patient was not treated with steroids. The onset of eosinophilic enteritis during interferon therapy is comparatively rare. In this case, PEG-IFN was considered to be the causative factor. Furthermore, we suggested that subserosal eosinophilic enteritis may have characteristic symptoms in patients having hepatic diseases treated with interferon.Entities:
Keywords: Chronic hepatitis C; Eosinophilic gastroenteritis; Pegylated interferon (PEG-IFN); Predominant subserosal layer disease
Year: 2012 PMID： 26182155 DOI： 10.1007/s12328-012-0289-2
Source DB: PubMed Journal: Clin J Gastroenterol ISSN： 1865-7265